Colorectal cancer cells with certain mutations "handle" vitamin C differently than other cells, and this difference ultimately kills them, a new study shows. They now hope that the findings could lead to the development of new treatments and provide critical insights into who would most benefit from them.
Dr. Cantley and his fellow researchers are positive that this discovery is a stepping stone that will help in developing treatments for colorectal cancer which roots from BRAF and KRAS mutant cells. "This combination of characteristics makes these cancer cells far more vulnerable to DHA than normal cells or other types of cancer cells". The new study by the group also stipulates who should receive the drug and who should not. The primary area that must be investigated in that of the effects that DHA can have on normal cells when absorbed into the human body in such high amounts.
A few smaller trials in the last 5 years for ovarian cancer and pancreatic cancer hinted that IV vitamin C treatment in combination with chemotherapy could extend survival for the cancer patient
A few smaller trials in the last 5 years for ovarian cancer and pancreatic cancer hinted that IV vitamin C treatment in combination with chemotherapy could extend survival for the cancer patient
Well, I wish someone would've told my grandmother this.
I've been having high strength vitamin c supplements for about 10 years now thx to my biochemistry friend who was obsessed with Linus Pauling. I think it only helps in high doses, i.e. 1000%+ recommended daily intake amounts.
I'm glad mainstream medicine is finally catching up.
(Don't think I'm into weird witch doctor ****, but small labs have been proving this for decades, not to mention Pauling himself)
